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Cardiopulmonary bypass in neonates generates large increases in inflamma-
tory mediators, causing edema formation that may lead to multiple organ
dysfunction. Clinical strategies aimed at removing inflammatory mediators,
reducing edema formation, and improving organ function include conventional
and modified ultrafiltration. Objective: This study examines the effectiveness of
conventional and modified ultrafiltration in preventing weight gain, myocar-
dial edema formation, and left ventricular dysfunction in neonatal piglets
undergoing cardiopulmonary bypass. Methods: In this randomized prospective
study, 18 1-week-old piglets were supported with cardiopulmonary bypass at
100 ml kg–1 z min–1, cooled to 25° C, exposed to 75 minutes of cardioplegic
arrest, rewarmed to 37° C, and weaned from bypass. Left ventricular myocar-
dial contractility was assessed by the preload-recruitable stroke work method,
with the use of a sonomicrometric two-dimensional cylindrical model, before
bypass and at 10, 60, and 120 minutes after separation from bypass. Results:
Total body weight gain was significantly less in the modified ultrafiltration
group than in either the conventional ultrafiltration group or the control group
(no filtration). Myocardial wet/dry ratios were also improved with modified
ultrafiltration, but not with conventional ultrafiltration, when compared with
no filtration (control group). Hemodynamically, modified ultrafiltration was
superior to conventional ultrafiltration and no filtration (control) in raising
the mean arterial pressure and increasing the left ventricular preload-
recruitable stroke work after bypass. Conclusion: Modified ultrafiltration is
superior to conventional ultrafiltration and no filtration in reducing the total
body weight gain, lessening myocardial edema, raising mean arterial pressure,
and improving left ventricular contractility in neonatal piglets undergoing
cardiopulmonary bypass and cardioplegic arrest. (J Thorac Cardiovasc Surg
1998;115:336-42)
Cardiopulmonary bypass (CPB) has become aneffective and relatively safe procedure for adults
undergoing cardiac operations. However, CPB is
still associated with a high morbidity and mortality
in neonates.1, 2 This increased mortality is partially
due to the greater complexity of the procedures
performed in neonates. However, neonates do not
respond to CPB as well as older patients do, and
some neonates undergo a dramatic inflammatory
reaction, leaving them with tissue edema, pulmo-
nary dysfunction, and poor cardiac performance.3
Experienced pediatric cardiac surgeons can now
repair almost all cardiac malformations within a few
days of life, but the neonate must still overcome the
obstacle of recovery from CPB.4, 5 Improved meth-
ods of CPB for neonates must be developed if the
field of pediatric cardiac surgery is to progress to its
full potential.
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The ideal CPB procedure would require no blood
products for priming, cause no inflammation, yield
no net water gain after CPB, and cause no organ
dysfunction. One way to achieve some of these goals
is the use of filtration as part of the CPB procedure.6
Ultrafiltration involves use of a semipermeable
membrane, similar to those used in dialysis, to
remove extra fluid and inflammatory mediators that
result from exposure to the CPB circuit.6-8
Ultrafiltration in CPB seeks to (1) filter mediators
of inflammation, (2) remove excess water, (3) im-
prove post-CPB organ function, and (4) reduce the
need for postoperative blood transfusion by provid-
ing hemoconcentration of blood from the CPB
circuit.
Currently two distinct methods for ultrafiltration
exist: ultrafiltration during CPB and ultrafiltration
after CPB. With conventional ultrafiltration, a filter
is connected in parallel with the CPB circuit, such
that during rewarming circuit blood can be filtered.6
Modified ultrafiltration also uses a filter, but it is
connected in series with the CPB circuit and is used
only after the patient is weaned from CPB, allowing
for both greater efficiency of filtration and greater
concentration of red cells from the circuit.7, 8
Early experience with the use of conventional
ultrafiltration in neonates demonstrated that this
method was not effective in achieving any of the
aforementioned goals of ultrafiltration.7 Thus, an
alternative method that used a more efficient filtra-
tion was developed.8 Modified ultrafiltration ap-
pears to lower the total body water gain and improve
the hemodynamic performance in children undergo-
ing CPB.7-9 However, the mechanisms of this im-
provement have not been elucidated. Furthermore,
a direct comparison of modified ultrafiltration with
conventional ultrafiltration has not been performed
in a controlled laboratory environment.
In this randomized prospective study in neonatal
piglets, we compared the effectiveness of modified
ultrafiltration, conventional ultrafiltration, and no
filtration (control group) on total body weight gain,
myocardial edema formation, left ventricular con-
tractility, and hemodynamic performance after
CPB.
Materials and methods
Preparation of piglets. All animals were studied with
the approval of the institution’s animal care and use
committee and in compliance with the “Guide for the
Care and Use of Laboratory Animals” prepared by the
Institute of Laboratory Animal Resources and published
by the National Institutes of Health (NIH publication No.
85-23, revised 1985). Eighteen 7- day-old piglets were
premedicated with intramuscular ketamine (20 mg z kg–1)
and methylprednisolone (40 mg z kg–1). Animals were
intubated and their lungs ventilated with a pressure-
controlled infant ventilator (Sechrist Industries, Anaheim,
Calif.). After a dose of fentanyl (50 mg z kg-1) and pancu-
ronium (0.1 mg z kg–1), anesthesia was maintained with a
continuous intravenous infusion of fentanyl (50 mg z
Fig. 1. CPB circuit with filter. During CPB, tubing clamps
are placed at 2 and 3 to exclude the filter. During modified
ultrafiltration, tubing clamps are placed at 1 and blood is
added from the reservoir through the filter as needed.
During conventional ultrafiltration, all tubing clamps are
removed.
Fig. 2. Left ventricle with four microcrystals and micro-
transducer in place.
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kg–1 z hr–1). A median sternotomy was performed and the
heart and great vessels were exposed by opening the
pericardium. Epicardial microcrystals were placed along
the minor and major axis of the left ventricle, and vessel
loops were placed around the superior and inferior venae
cavae. A 2.5 mm microtransducer was placed in the left
ventricle.
CPB circuit. A Minimax Plus hollow-fiber infant oxy-
genator (Medtronic, Inc., Anaheim, Calif.) was used with
standard tubing. The circuit was primed with whole blood
from a donor swine 15 minutes before the start of CPB. A
hematocrit value of 24% was achieved by dilution with
lactated Ringer’s solution. The reservoir prime volume
was 400 ml and the total prime volume was 650 ml in all
cases. An infant roller pump (Medtronic) was used and
the circuit was warmed to 37° C before the initiation of
CPB.
Conduct of CPB. CPB was instituted with the insertion
of an 8F arterial cannula in the ascending aorta and a
single 18F venous cannula in the right atrial appendage.
After 5 minutes of normothermic CPB at 100 ml z kg–1 z
min–1, the animals were then cooled to 25° C over 15
minutes. CPB was maintained at 25° C for 5 minutes while
the left atrium was vented. An aortic crossclamp was place
on the ascending aorta and cardioplegic solution (St.
Thomas’ Hospital solution) was injected into the root of
the aorta (10 ml z kg–1) over 90 seconds. The total isch-
emic time was 75 minutes in all groups. After the cross-
clamp was removed, the animals were randomized to the
modified ultrafiltration group (MUF group), conventional
ultrafiltration group (CUF group), or no filtration group
(control group). Piglets were kept at 25° C for 2 minutes,
rewarmed to 37° C, and weaned from CPB without ino-
tropic support.
Ultrafiltration. Animals in the control group received
no filtration. Animals in the CUF group were subjected to
continuous filtration during rewarming, removed volume
being replaced with lactated Ringer’s solution. Animals in
the MUF group were subjected to filtration for 15 min-
utes, 10 minutes after separation from CPB. A Cobe
ultrafilter (Cobe Laboratories, Houston, Tex.) was used in
both conventional and modified ultrafiltration. In both the
MUF and CUF groups, suction was applied to the filter to
maintain a continuous negative pressure across the mem-
brane (–125 mm Hg). During continuous and modified
ultrafiltration, the flow rate through the filter was kept at
10 ml z kg–1 z min–1 by means of a second roller pump (Fig.
1).
Determination of contractility. Contractility was deter-
mined by means of the preload-recruitable stroke work
(PRSW) method as described by Glower and associates.10
A cylindrical model, which has been previously validated
in this laboratory,11 was used with microcrystals on the
posterior and anterior left ventricle for the minor axis and
on the apex and the left atrioventricular groove for the left
ventricular major axis (Fig. 2). PRSW determinations
were made immediately before CPB, 10 minutes after
CPB, and at 60 and 120 minutes after CPB. Three
consecutive vena caval occlusions were used for each data
point, and results reflect data averaging of these points.
The data were acquired at 200 Hz, and individual beat
points were analyzed with the use of a VAX data analysis
system (Digital Laboratories, Milpitas, Calif.).
Statistics. Data were analyzed with statistical software
(Microsoft Corporation, Redmond, Wash.) with the use
of Student’s t test to compare results between groups at
single time points and an analysis of variance test to
compare the results between groups at multiple time
points. All results are expressed as the mean 6 the
standard error of the mean. Differences between groups
were considered significant at the p , 0.05 level.
Results
Total body weight gain. After induction of anes-
thesia all animals were weighed for determination of
pre-CPB mass. At the completion of the study,
piglets were weighed on the same scale while all
body fluids remained in situ. The mass gain was
496.7 6 61.4 gm in control animals, 584.2 6 51.6 gm
in the CUF group, and 284.2 6 82.4 gm in the MUF
group (p 5 0.001, MUF vs CUF; p 5 0.018, MUF vs
controls; Fig. 3).
Myocardial edema. The left ventricle, including
the septum, was isolated and weighed immediately
after the animal was euthanized. The specimens
were then placed into a drying oven for 1 week and
reweighed. The wet/dry ratio was determined by
dividing the wet mass by the dry mass as an index of
Fig. 3. Total body weight gain after CPB and 120 minutes
of recovery. *p , 0.05, MUF versus CUF group and MUF
versus control group.
Fig. 4. Left ventricular wet/dry mass ratios. *p , 0.05,
MUF versus CUF group and MUF versus control group.
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myocardial water content. Myocardial wet/dry ratios
were 4.81 6 0.11 in controls, 4.92 6 0.04 in the CUF
group, and 4.44 6 0.08 in the MUF group (p 5
0.0048, MUF vs CUF; p 5 0.05, MUF vs controls;
Fig. 4).
Hematocrit. The baseline hematocrit values were
32% 6 1% in controls, 31% 6 1% in the CUF
group, and 29% 6 2% in the MUF group. Ten
minutes after CPB, the hematocrit value was 29% 6
1% in controls, 30% 6 1% in the CUF group, and
28% 6 3% in the MUF group. Fifteen minutes of
MUF raised the hematocrit value such that it was
significantly greater than in both the control group
and the CUF group at 60 and 120 minutes after CPB
(Fig. 5).
Hemodynamics. The heart rates were not signif-
icantly different between the groups at any time
point (Fig. 6). As shown in Fig. 7, the mean arterial
pressures at baseline and 10 minutes after CPB were
also similar among all groups. At 60 minutes after
CPB, mean arterial pressures were 64.7 6 8.9 mm
Hg in the control group, 66.0 6 15.0 mm Hg in the
CUF group, and 93.5 6 9.4 mm Hg in the MUF
group. At 120 minutes after CPB, the mean arterial
pressures were 66.7 6 11.3 mm Hg in the control
group, 55.5 6 3.4 mm Hg in the CUF group, and
84.7 6 8.9 mm Hg in the MUF group (p 5 0.02,
MUF vs CUF; p 5 0.04, MUF vs controls; analysis
of variance).
Contractility. As shown in Fig. 8, the left ventric-
ular contractility determinations were similar in all
groups before CPB. At 10 minutes after CPB and
before modified ultrafiltration, the control and
MUF groups had a higher contractility than did the
CUF group. Contractility improved in the MUF
group at 60 minutes, continuing to increase at 120
minutes after CPB while remaining decreased after
CPB in both the control and CUF groups (p 5
0.008, MUF vs CUF; p 5 0.02, MUF vs controls;
analysis of variance).
Discussion
This study demonstrates that exposure to moder-
ate hypothermic CPB with a clinically relevant pe-
riod of protected myocardial ischemia results in
considerable cardiac dysfunction with associated
weight gain and an increase in the myocardial water
content. The decreased cardiac function was mani-
fest as a decreased mean arterial pressure and an
impaired left ventricular myocardial contractility.
Modified ultrafiltration alone was effective in reduc-
ing weight gain, lessening myocardial edema, and
improving left ventricular contractility.
The exact reasons for differences in the effective-
ness between modified and conventional ultrafiltra-
Fig. 5. Hematocrit value of piglets during the study pe-
riod. Only modified ultrafiltration was capable of raising
the hematocrit value and maintaining it significantly
higher after CPB.
Fig. 6. Heart rates of piglets during the study as deter-
mined by electrocardiographic tracings.
Fig. 7. Mean arterial pressure as determined by a femo-
ral catheter. *p , 0.01, MUF versus CUF group and MUF
versus control group.
The Journal of Thoracic and
Cardiovascular Surgery
Volume 115, Number 2
Daggett et al. 3 3 9
tion have not been fully elucidated. However, sev-
eral differences between the two methods deserve
consideration. First, modified ultrafiltration is per-
formed after the cessation of CPB, which offers the
advantage of more efficient filtration. Because the
volume to be filtered in the piglet is approximately
200 ml and the volume of the entire circuit including
the piglet is approximately 850 ml, modified ultra-
filtration is at least four times as efficient as conven-
tional ultrafiltration. Second, modified ultrafiltra-
tion allows the concentration of hematocrit and
other blood components, because the reservoir may
be completely drained during this process, whereas
conventional ultrafiltration requires that the reser-
voir volume be maintained while CPB is being
conducted. Last, modified ultrafiltration is per-
formed while blood is at body temperature and
circulating normally through the heart and lungs,
whereas conventional ultrafiltration is undertaken
as the blood is being heated above body tempera-
ture (38° to 39° C) and being “bypassed” from the
lungs. This may be of importance inasmuch as the
lungs are known to absorb activated leukocytes,12
which have been shown to contribute to the inflam-
matory process in the heart and other organs.12
Although conventional ultrafiltration was found
to be ineffective in this model of neonatal swine
undergoing CPB, this method of ultrafiltration has
been found efficacious in adult patients undergoing
similar procedures.13 Although studies comparing
modified and conventional ultrafiltration in adult
swine and neonatal swine have not been done, it was
the relative lack of effectiveness of conventional
ultrafiltration in neonatal patients that actually led
to the development of modified ultrafiltration.7 The
discrepancy between adults and neonates may be
related to the tendency of neonates to have a greater
inflammatory response from CPB,3 necessitating a
more efficient filtration process and a greater degree
of removal of excess water and inflammatory medi-
ators. Furthermore, adults have a higher glomerular
filtration rate than neonates, which suggests that
adults may be capable of achieving the same efficient
filtration with their own kidneys, obviating the need
for modified ultrafiltration.
It is not known, nor has it been determined in this
study, whether the beneficial effects of modified
ultrafiltration are due to the removal of “free water”
or to the removal of mediators of inflammation.
Several studies have clearly demonstrated that ul-
trafiltration lowers the serum levels of several fac-
tors known to contribute to postoperative organ
dysfunction.14, 15 Furthermore, “free water” and in-
flammatory factors are interrelated, because it is
inflammation that allows free water to leak from
capillaries and cause the tissue edema which leads to
organ dysfunction. In a recent clinical study, “short
duration” modified ultrafiltration alone was com-
pared with modified ultrafiltration and high-volume,
zero-balanced ultrafiltration.16 In this article, the
authors conclude that the combination of these
techniques resulted in a lower alveolar-arterial oxy-
gen gradient and afforded lower plasma levels of
tumor necrosis factor, interleukin-10, myeloperoxi-
dase, C3a, interleukin-1, and interleukin-6. This
study suggests that the “free water” removal of
modified ultrafiltration is more effective at improv-
ing pulmonary function when the plasma levels of
inflammatory cytokines have been lowered. Al-
though cytokines were not measured in our study, in
preliminary investigations we observed an immedi-
ate decrease in the PRSW when small amounts (10
ml) of the modified ultrafiltrate were reinfused. This
decrease in PRSW indicates that substances that act
as potent myocardial depressants are removed by
modified ultrafiltration. Further investigations di-
rected at the interaction of individual cytokines with
specific organs are warranted to delineate the mech-
anisms and prevent cardiopulmonary dysfunction in
systemic inflammatory reactions.
In our institution, modified ultrafiltration is used
routinely in pediatric patients undergoing CPB. The
clinical benefits of modified ultrafiltration have been
reported previously.7-9 This large animal study con-
curs with the clinical data and adds to our under-
standing of the benefits of modified ultrafiltration by
demonstrating its effects on myocardial function. In
summary, this study confirms that CPB causes an
increase in weight, myocardial edema, and de-
pressed cardiac function. Modified ultrafiltration
Fig. 8. PRSW determinations of the left ventricle. p ,
0.05, MUF versus CUF group and MUF versus control
group.
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was effective in lessening weight gain, reducing
myocardial edema formation, and improving cardiac
function, whereas conventional ultrafiltration was
not.
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Discussion
Dr. J. Nilas Young (Berkeley, Calif.). Dr. Daggett and
his colleagues at Duke have provided important informa-
tion regarding some of the significant physiologic effects
of an intraoperative intervention, namely ultrafiltration, in
a neonatal animal model. They have used sophisticated
data acquisition protocols that they helped to popularize.
The authors have demonstrated experimentally that
conventional ultrafiltration (i.e., dialysis on CPB) is not
beneficial in neonates and may in fact be detrimental, but
that modified ultrafiltration (i.e., dialysis after CPB) is
beneficial with regard to hematocrit levels, total body
weight gain, myocardial edema formation, and ventricular
contractility. Their experimental data and conclusions
appear to be validly obtained and statistically justified, and
their experimental data seem to corroborate the findings
of several other published, limited clinical studies.
It is interesting that mean arterial blood pressures after
modified ultrafiltration were markedly increased to hyper-
tensive levels for a neonate. Dr. Daggett, what do you
think was the cause of this arterial hypertension? Other
investigators have noted similar increases in systemic
blood pressure without an increase in peripheral vascular
resistance after modified ultrafiltration. In fact, some have
noted decreased pulmonary vascular resistance and im-
proved cardiac output. Do you have vascular resistance
data to share with us?
Dr. Daggett. Previous studies of CPB have demon-
strated that the viscosity of the blood is directly related to
the hematocrit value and that it is this increase in hemat-
ocrit value which increases the viscosity of the blood,
causing hypertension. However, on examining the rela-
tionship of the cardiac output and cardiac index, we found
that no statistically significant difference between the two
groups. I have no data on the systemic vascular resistance,
so I cannot directly comment on that.
Dr. Young. If part of the benefit of ultrafiltration is
removal of inflammatory mediators, why do you think that
conventional ultrafiltration might not be just as beneficial,
since these mediators could be removed presumably just
as well during CPB as after CPB? Were any measure-
ments made of inflammatory mediators? You mentioned
that reinfusion of the ultrafiltrate after modified ultrafil-
tration was associated with hemodynamic decompensa-
tion. Is this also true if the ultrafiltrate from conventional
ultrafiltration is reinfused?
Dr. Daggett. With regard to your first question, modi-
fied ultrafiltration is much more efficient than conven-
tional ultrafiltration; one of the fundamental problems
with conventional ultrafiltration is that the blood is being
filtered during CPB. Thus the inflammatory mediators can
never be removed, because they are being continuously
created during CPB. We did not specifically measure
inflammatory mediators in this study, although several
groups have demonstrated that both tumor necrosis factor
and interleukin-8 are decreased by this technique.
We did not study infusion in either of these groups. In
preliminary studies, however, the hemodynamic compromise
consisted mainly of pulmonary hypertension and cardiovas-
cular collapse with decreased cardiac output. The acute
nature and the small amount of volume that was infused
from both conventional ultrafiltrate and modified ultrafil-
The Journal of Thoracic and
Cardiovascular Surgery
Volume 115, Number 2
Daggett et al. 3 4 1
trate would suggest that the mediators of this hemodynamic
compromise were likely to be anaphylotoxins or other acute
mediators of inflammation, having a direct effect on myocar-
dial performance and pulmonary vascular resistance.
Dr. Young. Last, from a clinical standpoint, sometimes
a neonate who has just been weaned from CPB is not in
totally stable condition. What percentage of neonates
undergoing congenital heart surgery with CPB at Duke
receive modified ultrafiltration, and in those patients
receiving modified ultrafiltration, are the results similar to
those found in your piglet model?
Dr. Daggett. The vast majority of patients at Duke
undergo modified ultrafiltration. There are criteria for
exclusion, such as the need to be placed back on CPB or
immediate return to the intensive care unit. I would
emphasize that modified ultrafiltration is a very effective
clinical technique. These results were the same as those in
our neonatal clinical studies.
Dr. Edward D. Verrier (Seattle, Wash.). I think this issue
needs to be put into some context, and then I have a
question. There are as many studies in the literature
stating that no beneficial effect is derived from ultrafiltra-
tion as there are those that show the benefit. It is very
seductive to institute ultrafiltration at the end of CPB, get
a little bottle of water in front of you, and think: “this is
goodness.” There must be “bad things” that happen with
blood going through the artificial circuit, and now these
“bad things” end up in the bucket. What is in the filtered
fluid that is so bad, and why do you believe you saw such
a benefit? Ultrafiltration has not attracted much attention
in the adult literature, yet the same principles ought to be
applied. Adults have a bigger body surface area, so one
might argue there are more reasons to generate inflam-
matory mediators.
The question I have with your study, Dr. Daggett, is that
it is not randomized or blinded. During ultrafiltration,
how do you maintain fluid balance and how does that
relationship influence edema formation? Did you have to
add large amounts of saline solution to maintain hemo-
dynamics? Does the lack of randomness prejudice the
study results a priori?
Dr. Daggett. Thank you, Dr. Verrier. The reason mod-
ified ultrafiltration was developed initially was the
failure of conventional ultrafiltration. One of the rea-
sons for this failure is that the glomerular filtration rate
in neonates and infants is significantly less than it is in
adults. Adults may be able to accomplish the same thing
using their own kidneys with diuretics given at the time
of CPB, whereas neonates often have a decrease in
kidney function after CPB. That is one of the likely
reasons for the difference between pediatric patients
and adults.
To answer your question regarding randomization: The
animals were randomized just before being rewarmed.
The study was not blinded, of course, but the circuit was
constructed in an identical fashion in every case, with the
ultrafilter in place, so that the priming volume and other
parameters were identical. It was only after cardiac arrest
and before rewarming that we randomized to prevent
bias.
As far as returning fluid from the circuit to the animal,
during modified ultrafiltration enough was added to keep
the left atrial pressures the same in every group at the end
of CPB. That was our criterion for returning blood from
the cardiopulmonary reservoir. During conventional ul-
trafiltration, lactated Ringer’s solution was added to re-
place losses, such that the volume in the reservoir was the
same as when we started CPB.
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